eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.52-0.25 (-4.33%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

PS Ratio: N/A

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T12:51:27.667Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:51:27.667Z.

Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 51,233,102
TTM revenue · period ending 2026-06-30: 0

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EXOZ PS Ratio Metrics

PS RATIO

N/A

EXOZ Competitors' PS Ratio

EXOZ

eXoZymes, Inc.

Current

Market Cap

$51.23M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs EXOZ

Market Cap

$51.12M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs EXOZ

Market Cap

$51.58M

PS Ratio

N/A

TTM Avg

1293.91

3Y Avg

1758.59

5Y Avg

3330.34

APLM

Apollomics, Inc.

vs EXOZ

Market Cap

$50.51M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$50.25M

PS Ratio

242.77

TTM Avg

158.30

3Y Avg

158.03

5Y Avg

959.94

CLNN

Clene Inc.

vs EXOZ

Market Cap

$49.96M

PS Ratio

253.62

TTM Avg

342.08

3Y Avg

169.55

5Y Avg

218.69

ELOX

Eloxx Pharmaceuticals, Inc.

vs EXOZ

Market Cap

$52.95M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs EXOZ

Market Cap

$49.50M

PS Ratio

2.61

TTM Avg

0.93

3Y Avg

1.92

5Y Avg

8.84

IMA

ImageneBio Inc

vs EXOZ

Market Cap

$53.01M

PS Ratio

N/A

TTM Avg

51.20

3Y Avg

31.27

5Y Avg

27.74

BTMD

biote Corp.

vs EXOZ

Market Cap

$49.40M

PS Ratio

0.27

TTM Avg

0.38

3Y Avg

0.71

5Y Avg

0.59

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$51.23M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$51.12M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$51.58M	N/A	1293.91	1758.59	3330.34
Apollomics, Inc. (APLM)vs ›	$50.51M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$50.25M	242.77	158.30	158.03	959.94
Clene Inc. (CLNN)vs ›	$49.96M	253.62	342.08	169.55	218.69
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$52.95M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$49.50M	2.61	0.93	1.92	8.84
ImageneBio Inc (IMA)vs ›	$53.01M	N/A	51.20	31.27	27.74
biote Corp. (BTMD)vs ›	$49.40M	0.27	0.38	0.71	0.59

How this was calculated

Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.

Revenue calculation and filing references
Fiscal period	Revenue	Source
Q3 FY2025Period ended 2025-09-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13
Q4 FY2025Period ended 2025-12-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-30
Q1 FY2026Period ended 2026-03-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14
Q2 FY2026Period ended 2026-06-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13
TTM revenue	$0

The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.

These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio: N/A

EXOZ PS Ratio Metrics

EXOZ Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

Related Metrics